HKD39.96
1.16% today
Hong Kong, Sep 24, 10:08 am CET
ISIN
KYG970081173
Symbol
2269
Index

WuXi Biologics Target price 2025 - Analyst rating & recommendation

WuXi Biologics Classifications & Recommendation:

Buy
81%
Hold
19%

WuXi Biologics Price Target

Target Price HKD36.72
Price HKD39.96
Deviation
Number of Estimates 26
26 Analysts have issued a price target WuXi Biologics 2026 . The average WuXi Biologics target price is HKD36.72. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 32 analysts: 26 Analysts recommend WuXi Biologics to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the WuXi Biologics stock has an average upside potential 2026 of . Most analysts recommend the WuXi Biologics stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion HKD 20.42 23.93
9.63% 17.18%
EBITDA Margin 33.56% 34.83%
7.52% 3.79%
Net Margin 17.97% 21.09%
9.96% 17.36%

30 Analysts have issued a sales forecast WuXi Biologics 2025 . The average WuXi Biologics sales estimate is

HKD23.9b
Unlock
. This is
9.12% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD24.9b 13.41%
Unlock
, the lowest is
HKD22.6b 3.27%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD20.4b 9.63%
2025
HKD23.9b 17.18%
Unlock
2026
HKD27.7b 15.92%
Unlock
2027
HKD32.0b 15.30%
Unlock
2028
HKD37.5b 17.13%
Unlock
2029
HKD41.8b 11.50%
Unlock
2030
HKD46.3b 10.75%
Unlock
2031
HKD51.7b 11.88%
Unlock
2032
HKD56.9b 9.96%
Unlock

29 WuXi Biologics Analysts have issued a net profit forecast 2025. The average WuXi Biologics net profit estimate is

HKD5.0b
Unlock
. This is
9.98% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD6.0b 31.64%
Unlock
, the lowest is
HKD4.1b 11.63%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 HKD3.7b 1.28%
2025
HKD5.0b 37.51%
Unlock
2026
HKD5.9b 17.17%
Unlock
2027
HKD7.0b 18.08%
Unlock
2028
HKD7.7b 10.65%
Unlock
2029
HKD7.5b 2.59%
Unlock
2030
HKD8.7b 15.57%
Unlock
2031
HKD9.5b 9.32%
Unlock
2032
HKD10.6b 11.85%
Unlock

Net Margin

2024 17.97% 9.96%
2025
21.09% 17.36%
Unlock
2026
21.32% 1.09%
Unlock
2027
21.83% 2.39%
Unlock
2028
20.62% 5.54%
Unlock
2029
18.02% 12.61%
Unlock
2030
18.80% 4.33%
Unlock
2031
18.37% 2.29%
Unlock
2032
18.69% 1.74%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share HKD 0.86 1.24
1.18% 44.19%
P/E 31.85
EV/Sales 6.51

29 Analysts have issued a WuXi Biologics forecast for earnings per share. The average WuXi Biologics EPS is

HKD1.24
Unlock
. This is
14.81% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HKD1.48 37.04%
Unlock
, the lowest is
HKD1.00 7.41%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD0.86 1.18%
2025
HKD1.24 44.19%
Unlock
2026
HKD1.45 16.94%
Unlock
2027
HKD1.72 18.62%
Unlock
2028
HKD1.90 10.47%
Unlock
2029
HKD1.85 2.63%
Unlock
2030
HKD2.14 15.68%
Unlock
2031
HKD2.34 9.35%
Unlock
2032
HKD2.61 11.54%
Unlock

P/E ratio

Current 36.57 80.41%
2025
31.85 12.92%
Unlock
2026
27.18 14.66%
Unlock
2027
23.02 15.31%
Unlock
2028
20.81 9.60%
Unlock
2029
21.36 2.64%
Unlock
2030
18.48 13.48%
Unlock
2031
16.90 8.55%
Unlock
2032
15.11 10.59%
Unlock

Based on analysts' sales estimates for 2025, the WuXi Biologics stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.10 163.94%
2025
6.51 8.36%
Unlock
2026
5.61 13.73%
Unlock
2027
4.87 13.27%
Unlock
2028
4.16 14.62%
Unlock
2029
3.73 10.31%
Unlock
2030
3.37 9.71%
Unlock
2031
3.01 10.62%
Unlock
2032
2.74 9.05%
Unlock

P/S ratio

Current 7.47 150.85%
2025
6.85 8.36%
Unlock
2026
5.91 13.73%
Unlock
2027
5.12 13.27%
Unlock
2028
4.37 14.62%
Unlock
2029
3.92 10.31%
Unlock
2030
3.54 9.71%
Unlock
2031
3.17 10.62%
Unlock
2032
2.88 9.05%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today